Class Action Lawsuit Claims JUUL Manufacturer Exploited Teens

According to allegations raised in a recently filed class action claim against the makers of JUUL vaping products, manufacturers intentionally exploited teens to create a new generation of nicotine-addicted customers.

In a complaint (PDF) filed last month in the U.S. District Court for the Western District of Tennessee, plaintiff John Scott Emidy seeks to pursue damages against Juul Labs, Inc. Altria Group, and Philip Morris USA Inc. as defendants.

While teen vaping problems were bad before, the lawsuit notes that issues could become worse now that Philip Morris and it’s parent company, Altria Group, hold a 35% stake in JUUL Labs.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

“Now that JUUL has Altria’s infrastructure, progress in nicotine cessation stands to erode,” the lawsuit states. “Defendants use fraudulent and deceptive youth marketing business practices. They exploit themes that resonate with teenagers while falsely denying doing so.”

Emidy, of Tennessee, indicates he is one of those who has fallen prey to JUUL’s tactics. The 25 year old says he is now addicted to nicotine in JUUL, claiming the manufacturer emulated tactics known to have been used by the tobacco industry for years to entice underage customers.

JUUL Teen Addiction Concerns

Recent FDA data indicates teen e-cigarette use has reached epidemic levels in the United States, and JUUL Labs has been accused of fueling the growing teen nicotine addiction problems in the United States, through the design and marketing of their vape pen.

JUUL was intentionally designed to look like a USB thumb drive, which has made the product popular among teems who are able to hide their vaping habit from parents, teachers and other adults.

The manufacturer also marketed and sold JUUL in various candy-like flavors, which has resulted in a large number of teens and prior non-smokers starting to vape, and developing addictions to the high levels of nicotine contained in the pods.

A recent study found that e-cigarette advertising reaches 80% of middle and high school students in the U.S. Another study warns that vaping during adolescence quadruples a teen’s risk of becoming a cigarette tobacco smoker later.

On September 9, the FDA issued a warning letter to JUUL, indicating there was evidence it told school-aged children that its products were safer than cigarettes, which has not been proven.

In addition, federal and state health experts are investigating whether JUUL and other e-cigarettes are linked to hundreds of cases of respiratory illness, including at least 18 deaths, as well as investigating whether JUUL is linked to nearly 130 cases of e-cigarette-related seizures.

Following a recent federal survey that indicated a quarter of high school students vaped within the last 30 days, there has been rising concerns about the actions of JUUL Labs, which now faces a criminal probe over claims that it illegally marketed to children. In the wake of the problems, JUUL has suspended all advertising in the United States, and it’s CEO resigned.

Last month a panel of judges announced that JUUL claims pending throughout the federal court system will all be consolidated before Judge William H. Orrick III in the U.S. District Court for the Northern District of California, which is where JUUL Labs, Inc.’s San Francisco headquarters are located, and where five of the earliest complaints were filed.

As part of the consolidation into a MDL, all pretrial proceedings will be handled by Judge Orrick, but the cases will remain individual lawsuits. If settlements for JUUL nicotine addictions or another resolution is not reached during the pretrial proceedings, each case may eventually be transferred back to their originating districts for trial in the future.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 2 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 2 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.